T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
NextDecade
NEXT
$1.83B
| $128K | ﹤0.01% |
22,511
+2,458
| +12% | +$12.3K |
|
2727
Vivid Seats
SEAT
$83.7M
| $128K | ﹤0.01% |
+1,065
| New | +$125K |
|
|
HONE
2728
DELISTED
HarborOne Bancorp
HONE
| $126K | ﹤0.01% |
11,781
+1,498
| +15% | +$16.1K |
|
2729
LifeVantage
LFVN
$81M
| $126K | ﹤0.01% |
20,700
| – | – |
|
2730
LivePerson
LPSN
$34.5M
| $126K | ﹤0.01% |
8,357
+4,058
| +94% | +$140K |
|
2731
SES AI
SES
$214M
| $125K | ﹤0.01% |
74,278
+7,118
| +11% | +$10.7K |
|
|
QVCGA
2732
DELISTED
QVC Group Inc Series A
QVCGA
| $125K | ﹤0.01% |
2,025
+534
| +36% | +$27.9K |
|
2733
Omeros
OMER
$1.25B
| $122K | ﹤0.01% |
35,181
+2,248
| +7% | +$8.55K |
|
2734
Rush Street Interactive
RSI
$2.87B
| $122K | ﹤0.01% |
18,661
-29,193
| -61% | -$157K |
|
2735
Caribou Biosciences
CRBU
$160M
| $121K | ﹤0.01% |
23,380
+2,545
| +12% | +$15.7K |
|
2736
GCM Grosvenor
GCMG
$2.81B
| $121K | ﹤0.01% |
12,461
+2,341
| +23% | +$20.4K |
|
|
SYRS
2737
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $121K | ﹤0.01% |
22,550
| – | – |
|
2738
Grindr
GRND
$2.71B
| $120K | ﹤0.01% |
11,796
+1,667
| +16% | +$14.8K |
|
2739
TaskUs
TASK
$655M
| $119K | ﹤0.01% |
10,200
| – | – |
|
2740
TeraWulf
WULF
$8.15B
| $119K | ﹤0.01% |
45,082
+6,450
| +17% | +$12.7K |
|
2741
Quantum-Si Incorporated
QSI
$189M
| $118K | ﹤0.01% |
59,727
+5,945
| +11% | +$10.4K |
|
|
VIA
2742
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $118K | ﹤0.01% |
10,880
| – | – |
|
2743
Nektar Therapeutics
NKTR
$2.56B
| $117K | ﹤0.01% |
8,317
| – | – |
|
2744
Seer Inc
SEER
$115M
| $114K | ﹤0.01% |
59,580
+25,441
| +75% | +$45.7K |
|
2745
Ardagh Metal Packaging
AMBP
$3.13B
| $113K | ﹤0.01% |
32,881
+4,922
| +18% | +$17.6K |
|
2746
NextNav
NN
$3.32B
| $113K | ﹤0.01% |
17,025
+4,405
| +35% | +$19.6K |
|
2747
Telos
TLS
$336M
| $113K | ﹤0.01% |
27,006
| – | – |
|
|
FFWM
2748
DELISTED
First Foundation Inc
FFWM
| $112K | ﹤0.01% |
14,766
+1,480
| +11% | +$12.7K |
|
|
PRPH
2749
DELISTED
ProPhase Labs
PRPH
| $112K | ﹤0.01% |
1,730
| – | – |
|
|
CTLP
2750
DELISTED
Cantaloupe
CTLP
| $111K | ﹤0.01% |
17,109
+3,197
| +23% | +$21.1K |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.